Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Geron Corporation (GERN)

-NasdaqGS
3.95 Down 0.07(1.74%) May 22, 4:00PM EDT
|After Hours : 3.95 0.00 (0.00%) May 22, 4:25PM EDT
Add to Portfolio
Prev Close:4.02
Open:4.02
Bid:3.85 x 4000
Ask:4.00 x 300
1y Target Est:5.50
Beta:2.34
Earnings Date:Aug 10 - Aug 14 (Est.)
Day's Range:3.89 - 4.06
52wk Range:1.76 - 4.49
Volume:1,339,335
Avg Vol (3m):3,906,780
Market Cap:624.45M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 1.74%624.45M
BMYDown 0.86%113.85B
GSKDown 0.66%109.30B
NVSDown 0.90%251.35B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):522.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.07
Quarterly EPS Est (Jun-15) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-11.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback